Back
ClearPoint Neuro Vs. Perspective Therapeutics Industry Stock Comparison
Sell
35
CLPT
ClearPoint Neuro
Last Price:
12.00
Seasonality Move:
9.94%
Sell
30
CATX
Perspective Therapeutics
Last Price:
4.25
Seasonality Move:
34.33%
Sell
35
ClearPoint Neuro (CLPT)
is a Sell
Is ClearPoint Neuro a Buy, Sell or Hold?
- The current ClearPoint Neuro [CLPT] share price is $11.96. The Score for CLPT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- CLPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $4.40. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CLPT Stock Price Chart
What is ClearPoint Neuro's stock price today?
-
The ClearPoint Neuro share price today is $11.96
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $4.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing slight buying pressure.
CLPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.19 | Sell |
Relative Strength Index (14 RSI): | 52.25 | Buy |
Chaikin Money Flow: | 73872 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (11.16 - 12.92) | Sell |
Bollinger Bands (100): | (8.55 - 12.85) | Buy |
CATX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -2.23 | Sell |
Relative Strength Index (14 RSI): | 23.26 | Sell |
Chaikin Money Flow: | 1034740 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.36 - 12.6) | Sell |
Bollinger Bands (100): | (9.83 - 14.93) | Sell |
CLPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.27 | Buy |
20-day SMA: | 11.85 | Buy |
50-day SMA: | 11.89 | Buy |
200-day SMA: | 8.42 | Buy |
8-day EMA: | 11.53 | Buy |
20-day EMA: | 11.7 | Buy |
50-day EMA: | 11.61 | Buy |
200-day EMA: | 9.34 | Buy |
CATX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.29 | Sell |
20-day SMA: | 8.91 | Sell |
50-day SMA: | 11.17 | Sell |
200-day SMA: | 12.67 | Sell |
8-day EMA: | 5.39 | Sell |
20-day EMA: | 7.89 | Sell |
50-day EMA: | 10.36 | Sell |
200-day EMA: | 11.21 | Sell |
ClearPoint Neuro Earnings Growth & CLPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.24 per share, and an increase next year of $0.09 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.
ClearPoint Neuro Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Perspective Therapeutics Technical Analysis
Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |